The carboxyl-terminal domain of RNA polymerase II is phosphorylated by a complex containing cdk9 and infected-cell protein 22 of herpes simplex virus 1

Journal of Virology

Volumn 79, Issue 11, 2005, Pages 6757-6762

  Durand, Lizette O ^a   Advani, Sunil J ^a   Poon, Alice P W ^a   Roizman, Bernard ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLIN B; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 9; CYCLIN T1; DNA TOPOISOMERASE; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; INFECTED CELL PROTEIN 22; PROTEIN KINASE; REGULATOR PROTEIN; RNA POLYMERASE II; TOPOISOMERASE 2ALPHA; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL LYSATE; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; ENZYME PHOSPHORYLATION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION; VIRUS REPLICATION; WILD TYPE;

CELL LINE; CYCLIN-DEPENDENT KINASE 9; CYCLINS; GENES, VIRAL; HERPESVIRUS 1, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; MOLECULAR WEIGHT; MULTIPROTEIN COMPLEXES; MUTATION; PHOSPHORYLATION; PROTEIN KINASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; RNA POLYMERASE II; VIRUS REPLICATION;

HERPES; HUMAN HERPESVIRUS 1;

EID: 18744373339     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.11.6757-6762.2005     Document Type: Article

References (31)

1. - deletion mutant. J. Virol. 56:207-215.
2. L13 viral genes. J. Virol. 74:8-15.
3. Advani, S. J., R. R. Weichselbaum, and B. Roizman. 2000. The role of cdc2 in the expression of herpes simplex virus genes. Proc. Natl. Acad. Sci. USA 97:10996-11001.
4. L42 DNA synthesis processivity factor. J. Virol. 75:10326-10333.
5. Advani, S. J., R. R. Weichselbaum, and B. Roizman. 2003. Herpes simplex virus 1 activates cdc2 to recruit topoisomerase IIα for post-DNA synthesis expression of late genes. Proc. Natl. Acad. Sci. USA 100:4825-4830.
6. Bregman, D. B., R. G. Pestell, and V. J. Kidd. 2000. Cell cycle regulation and RNA polymerase II. Front. Biosci. 5:244-257.
7. Coqueret, O. 2002. Linking cyclins to transcriptional control. Gene 299:35-55.
8. Ejercito, P., E. D. Kieff, and B. Roizman. 1968. Characterization of herpes simplex virus strains differing in their effects on social behavior of infected cells. J. Gen. Virol. 2:357-364.
9. Gitig, D. M., and A. Koff. 2000. Cdk pathway: cyclin-dependent kinases and cyclin-dependent kinase inhibitors. Methods Mol. Biol. 142:109-123.
10. Herrmann, C. H., and M. A. Mancini. 2001. The Cdk9 and cyclin T subunits of TAK/P-TEFb localize to splicing factor-rich nuclear speckle regions. J. Cell Sci. 114:1491-1503.
11. 2/M transition. Cancer Surv. 29:47-73.
12. Jenkins, H. L., and C. A. Spencer. 2001. RNA polymerase II holoenzyme modifications accompany transcription reprogramming in herpes simplex virus type 1-infected cells. J. Virol. 75:9872-9884.
13. John, P. C., M. Mews, and R. Moore. 2001. Cyclin/Cdk complexes: their involvement in cell cycle progression and mitotic division. Protoplasma 216:119-142.
14. L13 protein kinase are both required for herpes simplex virus-induced modification of the large subunit of RNA polymerase II. J. Virol. 73:5593-5604.
15. Napolitano, G., B. Majello, and L. Lania. 2002. Role of cyclin T/Cdk9 complex in basal and regulated transcription. Int. J. Oncol. 21:171-177.
16. Neugebauer, K. M. 2002. On the importance of being co-transcriptional. J. Cell Sci. 115:3865-3871.
17. Obaya, A. J., and J. M. Sedivy. 2002. Regulation of cyclin-Cdk activity in mammalian cells. Cell. Mol. Life Sci. 59:126-142.
18. Oelgeschlager, T. 2002. Regulation of RNA polymerase II activity by CTD phosphorylation and cell cycle control. J. Cell. Physiol. 190:160-169.
19. Post, L. E., S. Mackem, and B. Roizman. 1981. Regulation of alpha genes of herpes simplex virus: expression of chimeric genes produced by fusion of thymidine kinase with alpha gene promoters. Cell 24:555-565.
20. Post, L. E., and B. Roizman. 1981. A generalized technique for deletion of specific genes in large genomes: α gene 22 of herpes simplex virus 1 is not essential for growth. Cell 25:227-232.
21. Price, D. H. 2000. P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II. Mol. Cell. Biol. 20:2629-2634.
22. Purves, F. C., R. M. Longnecker, D. P. Leader, and B. Roizman. 1987. Herpes simplex virus 1 protein kinase is encoded by open reading frame US3 which is not essential for virus growth in cell culture. J. Virol. 61:2896-2901.
23. L13 protein kinase determines the accumulation of a subset of α and γ mRNAs and proteins in infected cells. Proc. Natl. Acad. Sci. USA 90:6701-6705.
24. L13 gene of herpes simplex virus 1 encodes the functions for posttranslational processing associated with phosphorylation of the regulatory protein α22. Proc. Natl. Acad. Sci. USA 89:7310-7314.
25. I/S transition. Cancer Surv. 29:7-23.
26. Rice, S. A., M. C. V. Lam, P. A. Schafler, and C. A. Spencer. 1995. Herpes simplex virus immediate-early protein ICP22 is required for viral modification of host RNA polymerase II and establishment of the normal viral transcription program. J. Virol. 69:5550-5559.
27. Sears, A. E., I. W. Halliburton, B. Meignier, S. Silver, and B. Roizman. 1985. Herpes simplex virus mutant deleted in the α22 gene: growth and gene expression in permissive and restrictive cells and establishment of latency in mice. J. Virol. 55:338-346.
28. Schafer, K. A. 1998. The cell cycle: a review. Vet. Pathol. 35:461-478.
29. Spencer, C. A., M. E. Dahmus, and S. A. Rice. 1997. Repression of host RNA polymerase II transcription by herpes simplex virus type 1. J. Virol. 71:2031-2040.
30. Taube, R., K. Fujinaga, J. Wimmer, M. Barboric, and B. M. Peterlin. 1999. Tat transactivation: a model for the regulation of eukaryotic transcription elongation. Virology 265:245-253.
31. Wang, J. C. 2002. Cellular roles of DNA topoisomerases: a molecular perspective. Nat. Rev. Mol. Cell Biol. 3:430-440.